Tracing expert thinking in clinical trial design

Marcio Malogolowkin, Roberta S. Horowitz, Jorge A. Ortega, Stuart E. Siegel, G. Denman Hammond, John M. Weiner

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This paper describes a method for the analysis of the clinical trial design process used by experts. With this procedure, the scientific ideas and their sources can be identified and related to the clinical trial protocol actually prepared by the experts. An example is given using the work of the Intergroup Rhabdomyosarcoma Study Committee (IRS). That committee has been the primary contributor of information dealing with the treatment of rhabdomyosarcoma inchildren. The IRS-III protocol was used in this analysis of expert behavior because the protocol was adopted by the leading pediatric oncology clinical trial groups in North America and Europe. The analysis showed that the experts rely heavily, for much of the design, on ideas presented in numerical displays in published documents. Further, those aspects of the design which are innovative can be traced and better understood by applying the new procedure.

Original languageEnglish (US)
Pages (from-to)190-208
Number of pages19
JournalComputers and Biomedical Research
Volume22
Issue number2
DOIs
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Rhabdomyosarcoma
Clinical Trials
Clinical Protocols
Pediatrics
Oncology
North America
Display devices
Therapeutics

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Malogolowkin, M., Horowitz, R. S., Ortega, J. A., Siegel, S. E., Hammond, G. D., & Weiner, J. M. (1989). Tracing expert thinking in clinical trial design. Computers and Biomedical Research, 22(2), 190-208. https://doi.org/10.1016/0010-4809(89)90025-6

Tracing expert thinking in clinical trial design. / Malogolowkin, Marcio; Horowitz, Roberta S.; Ortega, Jorge A.; Siegel, Stuart E.; Hammond, G. Denman; Weiner, John M.

In: Computers and Biomedical Research, Vol. 22, No. 2, 01.01.1989, p. 190-208.

Research output: Contribution to journalArticle

Malogolowkin, M, Horowitz, RS, Ortega, JA, Siegel, SE, Hammond, GD & Weiner, JM 1989, 'Tracing expert thinking in clinical trial design', Computers and Biomedical Research, vol. 22, no. 2, pp. 190-208. https://doi.org/10.1016/0010-4809(89)90025-6
Malogolowkin, Marcio ; Horowitz, Roberta S. ; Ortega, Jorge A. ; Siegel, Stuart E. ; Hammond, G. Denman ; Weiner, John M. / Tracing expert thinking in clinical trial design. In: Computers and Biomedical Research. 1989 ; Vol. 22, No. 2. pp. 190-208.
@article{f68318c615134a229048a0c4fa2485d0,
title = "Tracing expert thinking in clinical trial design",
abstract = "This paper describes a method for the analysis of the clinical trial design process used by experts. With this procedure, the scientific ideas and their sources can be identified and related to the clinical trial protocol actually prepared by the experts. An example is given using the work of the Intergroup Rhabdomyosarcoma Study Committee (IRS). That committee has been the primary contributor of information dealing with the treatment of rhabdomyosarcoma inchildren. The IRS-III protocol was used in this analysis of expert behavior because the protocol was adopted by the leading pediatric oncology clinical trial groups in North America and Europe. The analysis showed that the experts rely heavily, for much of the design, on ideas presented in numerical displays in published documents. Further, those aspects of the design which are innovative can be traced and better understood by applying the new procedure.",
author = "Marcio Malogolowkin and Horowitz, {Roberta S.} and Ortega, {Jorge A.} and Siegel, {Stuart E.} and Hammond, {G. Denman} and Weiner, {John M.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0010-4809(89)90025-6",
language = "English (US)",
volume = "22",
pages = "190--208",
journal = "Journal of Biomedical Informatics",
issn = "1532-0464",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Tracing expert thinking in clinical trial design

AU - Malogolowkin, Marcio

AU - Horowitz, Roberta S.

AU - Ortega, Jorge A.

AU - Siegel, Stuart E.

AU - Hammond, G. Denman

AU - Weiner, John M.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - This paper describes a method for the analysis of the clinical trial design process used by experts. With this procedure, the scientific ideas and their sources can be identified and related to the clinical trial protocol actually prepared by the experts. An example is given using the work of the Intergroup Rhabdomyosarcoma Study Committee (IRS). That committee has been the primary contributor of information dealing with the treatment of rhabdomyosarcoma inchildren. The IRS-III protocol was used in this analysis of expert behavior because the protocol was adopted by the leading pediatric oncology clinical trial groups in North America and Europe. The analysis showed that the experts rely heavily, for much of the design, on ideas presented in numerical displays in published documents. Further, those aspects of the design which are innovative can be traced and better understood by applying the new procedure.

AB - This paper describes a method for the analysis of the clinical trial design process used by experts. With this procedure, the scientific ideas and their sources can be identified and related to the clinical trial protocol actually prepared by the experts. An example is given using the work of the Intergroup Rhabdomyosarcoma Study Committee (IRS). That committee has been the primary contributor of information dealing with the treatment of rhabdomyosarcoma inchildren. The IRS-III protocol was used in this analysis of expert behavior because the protocol was adopted by the leading pediatric oncology clinical trial groups in North America and Europe. The analysis showed that the experts rely heavily, for much of the design, on ideas presented in numerical displays in published documents. Further, those aspects of the design which are innovative can be traced and better understood by applying the new procedure.

UR - http://www.scopus.com/inward/record.url?scp=0024541852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024541852&partnerID=8YFLogxK

U2 - 10.1016/0010-4809(89)90025-6

DO - 10.1016/0010-4809(89)90025-6

M3 - Article

VL - 22

SP - 190

EP - 208

JO - Journal of Biomedical Informatics

JF - Journal of Biomedical Informatics

SN - 1532-0464

IS - 2

ER -